. Verification: 8ea7dd8e8067cf6e

Well, it seems like the CDC has taken its expertise in both politics and science to a whole new level with its stance on trans women breastfeeding. Who needs research and transparency when you can blur the lines and leave everyone guessing about the potential health risks to infants? It's truly remarkable how they've managed to juggle politics and science in a way that would make even the most seasoned acrobat jealous. Perhaps next, they'll unveil a groundbreaking act where they simultaneously solve global warming while performing a magic trick. Bravo, CDC, bravo. Your ability to navigate the treacherous waters of politics and science deserves a standing ovation. Or maybe just a good, sarcastic eye-roll. But hey, who needs facts when you have the thrill of uncertainty, right?

The US Centers for Disease Control and Prevention (CDC) has come under fire for allegedly blurring the lines between politics and science in their advice on trans women breastfeeding. Concerns have been raised about the CDC's failure to mention potential health risks to infants while endorsing the practice of "chestfeeding" by trans and non-binary parents. In this article, we delve into the controversy surrounding the CDC's stance and shed light on the need for transparent and comprehensive information.

Trans Women and Chestfeeding: Unveiling the CDC's Recommendations

The CDC's website includes information pages that seemingly endorse the practice of "chestfeeding" by trans and non-binary parents. These individuals can stimulate lactation by taking a combination of drugs, but it's important to note that these drugs are not without risks.

One particular section on the CDC website, titled "Health Equity Considerations," states that an individual does not need to have given birth to breastfeeding or chestfeeding. Additionally, a Q&A section on breast surgery acknowledges the potential need for medication to induce lactation in transgender parents.

However, medical professionals argue that the CDC should disclose the lack of research and potential risks associated with these practices. Notably, one of the medications used to promote milk production in biological men has been linked to heart problems in infants. Critics claim that the CDC's stance blurs the line between politics and science.

The CDC's Silence and Medical Concerns

Despite requests for comment, the CDC has not responded to concerns raised about their recommendations on trans women breastfeeding. This lack of engagement has only fueled further criticism.

When biological men transition to women, they can produce breast milk by undergoing hormone therapy that simulates the changes a woman's body undergoes during and after pregnancy. However, one of the drugs used in this process can enter breast milk in small amounts, potentially causing irregular heartbeats in infants.

The US Food and Drug Administration (FDA) has issued a warning against the use of domperidone, an anti-nausea drug that increases prolactin levels and promotes milk production. The FDA advises breastfeeding women not to use domperidone due to the possibility of serious adverse effects.

The Importance of Transparency and Long-Term Effects

Dr. Jane Orient, executive director of the conservative Association of American Physicians and Surgeons, has emphasized the need for transparency and caution when it comes to breastfeeding trans women. She raises concerns about the long-term effects on children when transgender women use off-label hormones for inducing lactation.

Off-label use refers to using a medication for a purpose other than its approved indication. Some medications required to stimulate lactation in trans women are not approved for enhancing milk production in the United States. Dr. Orient asserts that the CDC has a responsibility to discuss the health risks associated with these practices, but their failure to do so has been a dereliction of duty.


The controversy surrounding the CDC's recommendations on trans women breastfeeding has highlighted the need for transparency, comprehensive research, and clear communication. Critics argue that the CDC's failure to disclose potential health risks to infants while endorsing the practice of chestfeeding blurs the line between politics and science. Medical professionals emphasize the importance of understanding the long-term effects of off-label hormone use in breastfeeding trans women. Moving forward, it is crucial for health organizations to provide accurate and balanced information, ensuring the well-being of both parents and infants.

We need your help to continue to post news that matters...You can support our efforts by buying us a coffee... It’s quick, secure, and easy. https://gogetfunding.com/realnewscast/